NLRP3 and familial dilated cardiomyopathy: Treatment with MCC950, which is known as an inhibitor of NLRP3, significantly reduced the damaged cardiac function and significantly inhibited the expression of NLRP3 and GSDMDNT in the hearts of DCM rats [76].